EDIT 8-K 2026-10-08

Editas Medicine, Inc. (EDIT) 8-K dated 2026-10-08 — accession 0001650664-26-000093. This URL is the filing, not the EDIT hub.

Editas Medicine, Inc. (EDIT) is a biotechnology company listed on NASDAQ.

Editas Medicine, Inc. filed a 8-K on 2026-10-08. Accession 0001650664-26-000093.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported EDIT revenue for 2025-12-31 was $40.5M. Net income was -$160.1M. Revenue was up 25.4% from 2024-12-31 to 2025-12-31. EDIT currently screens at market cap $375.2M.

Not investment advice. The EDIT SEC hub lists recent forms. The stock page is the research view.